Showing 1 - 3 results of 3 for search 'P.F.A. Mulders', query time: 0.03s Refine Results
  1. 1
    Therapeutic efficacy and tolerability of [225Ac]Ac-DOTA-hG250 targeted alpha therapy in a clear cell renal cell carcinoma mice model

    Therapeutic efficacy and tolerability of [225Ac]Ac-DOTA-hG250 targeted alpha therapy in a clear cell renal cell carcinoma mice model by R. Merkx, A. Kip, G.M. Franssen, E. Oosterwijk, A. Morgenstern, F. Bruchertseifer, M. Wheatcroft, E. Yan, M. Rijpkema, S. Heskamp, P.F.A. Mulders

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab

    Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab by T.J. Van Oostenbrugge, J.F. Langenhuijsen, E. Oosterwijk, O.C. Boerman, S.F. Jenniskens, W.J.G. Oyen, J.J. Fütterer, P.F.A. Mulders

    Published 2020-07-01
    Get full text
    Article
  3. 3
    The SelectMDx urinary-biomarker test: Role in the detection of high-grade prostate cancer and in combination with multi-parametric magnetic resonance imaging in a contemporary prospective cohort of biopsy-naïve men

    The SelectMDx urinary-biomarker test: Role in the detection of high-grade prostate cancer and in combination with multi-parametric magnetic resonance imaging in a contemporary pros... by R.J. Hendriks, M.M.G. Van Der Leest, B. Israël, G. Hannink, A. Yantisetiasti, E.B. Cornel, C.A. Hulsbergen-Van De Kaa, O.S. Klaver, J.P.M. Sedelaar, W. Van Criekinge, H. De Jong, P.F.A. Mulders, J. Veltman, J.A. Schalken, J.O. Barentsz, I.M. Van Oort

    Published 2020-07-01
    Get full text
    Article

Search Tools: